Article Sidebar
Article Details
Issue
Section
Articles
A. AFRICAN HEALTH SCIENCES OPEN ACCESS POLICY
While African Health Sciences has been freely accessible online there have been questions on whether it is Open Access or not. We wish to clearly state that indeed African Health Sciences is Open Access. There are key issues regarding Open Access needing clarification for avoidance of doubt:
- 1. Henceforth, papers in African Health Sciences will be published under the CC BY (Creative Commons Attribution License) 4.0 International. See details on https://creativecomons.org/)
- 2. The copyright owners or the authors grant the 3rd party (perpetually and in advance) the right to disseminate, reproduce, or use the research papers in part or in full, format/medium as long as:
- No substantive errors are introduced in the process
- Attribution of authorship and correct citation details are given
- The referencing details are not changed.
Should the papers be reproduced in part, this must be clearly stated.
- 3. The papers will be freely and universally accessible online in an easily readable format such as XML in at least one widely recognized open access repository such as PUBMED CENTRAL.
B. ABRIDGED LICENCE AGREEMENT BETWEEN AUTHORS AND African Health Sciences
I submitted my manuscript to African Health Sciences and would like to affirm that:
1.0 I am authorized by my co-authors to enter into these arrangements.
2.0 I guarantee, on behalf of self and co-authors:
- That the paper is original, and has not been published in any other peer-reviewed journal; nor is it under consideration by other journal (s). It does not infringe existing copyright or any other person’s rights
- That we are/I am the sole author(s) of the paper and with authority to enter into this agreement. My granting rights to African Health Sciences is not in breach of any other obligation
- That the paper contains nothing unlawful, or libelous. Nor anything that would constitute a breach of contract, confidence or commitment given to secrecy, if published
- That I/we have taken care to ensure the integrity of the article.
3.0 I and all co-authors, agree that the paper, if accepted for publication, shall be licensed under the Creative Commons Attribution License 4.0. (see https://creativecommons.org/)
Main Article Content
Editorial: In this issue
Abstract
Happy birthday African Health Sciences! Today we celebrate the first birthday of our journal with humility but also with a sense of satisfaction. In our continent where the infant mortality rate for both humans and journals is very high, survival ushers in a sense of satisfaction and increased responsibility for the future.
We are particularly grateful to Nelson Sewankambo the dean of Makerere University Faculty of Medicine, Drs Walker and Samba of the WHO for seeing us through this first year. Many thanks also to all our editorial colleagues and referees both in Uganda and abroad for giving us the confidence to publish only vigorously reviewed work. And of course to you our reader who gives us the reason for existing: we thank you very much!
Talking of the future: we have in plan to make African Health Science available to our readers on the Internet. That will be a subject of future discussion.
Back to this birth-day issue of our journal. We have a selection of very interesting articles both general and specific. Dr. Dan Kaye's article on gestational trophoblastic disease following complete hydatidiform mole1, gives a glimpse of the clinical epidemiology, prevention and treatment of that condition. Although it occurs in just over 3 per 1000 deliveries, hydatidiform mole occurs in women with high fertility and is associated with mortality and protean complications of treatment. This is interesting information since there seems to be strong evidence from the 2001 Uganda Demographic Health Survey results linking high fertility rates and poverty.
Underlying our commitment to promoting evidence based practice, we publish Dr. Wabinga's article in which he compares the reliability of Giemsa stain with immunohistochemistry in the demonstration of H.pylori: the germ linked to duodenal ulcer and gastric carcinoma2. Despite the relatively small numbers of patients studied, indications from this study are that Giemsa stain had high positive and negative predictive values with good agreement between the two tests. Given that Giemsa stain is cheap and easily available in most laboratories in the developed countries, recommending its use, as Webbing does, is not altogether out of place.
To our old friend: cotrimoxazole! Now ubiquitously used in primary care settings for treatment of acute respiratory infections and for the prevention of Pneumocystis carinii pneumonia in HIV infected children and adults, cotrimoxazole seems destined to stay. Of major concern however is quality control of our products in an environment where sophisticated and time-consuming procedures may not always be possible. Balyejjussa, Adome and Musoke3 have used a rapid method (derivative spectrophotometry) for getting assays of the two components of cotrimoxazole with success.
In their article on monitoring the severity of iodine deficiency disorders in Uganda, Bimenya, Olio-Okui and colleagues4 found that the prevalence of goitre has declined with the introduction of iodised salt in the country in in the early 1990s. Despite this significant fall, the rates are much higher than those recommended by the WHO and therefore iodine deficiency disorders are still of public health significance. The over consumption of iodine and its possible association with hyperthyroidism in some districts of Uganda needs urgent investigation.
It is probably appropriate to end this review with two papers: one on eye disorders amongst school children and the other on the role of community health workers in DOTs in South Africa. Drs. Kawuma and Mayeku5 have found a high prevalence of astigmatism and, surprisingly, not short sight! The implications of these refractive disorders are discussed. Kironde and Bajunirwe6 leave us with an interesting debate of a re-emerging health problem with an old solution: using community health workers in DOTs. When you follow the history of primary health care and Alma Ata, you cannot but help beat off the sense of dejavu. Nobody will blame you!
We are particularly grateful to Nelson Sewankambo the dean of Makerere University Faculty of Medicine, Drs Walker and Samba of the WHO for seeing us through this first year. Many thanks also to all our editorial colleagues and referees both in Uganda and abroad for giving us the confidence to publish only vigorously reviewed work. And of course to you our reader who gives us the reason for existing: we thank you very much!
Talking of the future: we have in plan to make African Health Science available to our readers on the Internet. That will be a subject of future discussion.
Back to this birth-day issue of our journal. We have a selection of very interesting articles both general and specific. Dr. Dan Kaye's article on gestational trophoblastic disease following complete hydatidiform mole1, gives a glimpse of the clinical epidemiology, prevention and treatment of that condition. Although it occurs in just over 3 per 1000 deliveries, hydatidiform mole occurs in women with high fertility and is associated with mortality and protean complications of treatment. This is interesting information since there seems to be strong evidence from the 2001 Uganda Demographic Health Survey results linking high fertility rates and poverty.
Underlying our commitment to promoting evidence based practice, we publish Dr. Wabinga's article in which he compares the reliability of Giemsa stain with immunohistochemistry in the demonstration of H.pylori: the germ linked to duodenal ulcer and gastric carcinoma2. Despite the relatively small numbers of patients studied, indications from this study are that Giemsa stain had high positive and negative predictive values with good agreement between the two tests. Given that Giemsa stain is cheap and easily available in most laboratories in the developed countries, recommending its use, as Webbing does, is not altogether out of place.
To our old friend: cotrimoxazole! Now ubiquitously used in primary care settings for treatment of acute respiratory infections and for the prevention of Pneumocystis carinii pneumonia in HIV infected children and adults, cotrimoxazole seems destined to stay. Of major concern however is quality control of our products in an environment where sophisticated and time-consuming procedures may not always be possible. Balyejjussa, Adome and Musoke3 have used a rapid method (derivative spectrophotometry) for getting assays of the two components of cotrimoxazole with success.
In their article on monitoring the severity of iodine deficiency disorders in Uganda, Bimenya, Olio-Okui and colleagues4 found that the prevalence of goitre has declined with the introduction of iodised salt in the country in in the early 1990s. Despite this significant fall, the rates are much higher than those recommended by the WHO and therefore iodine deficiency disorders are still of public health significance. The over consumption of iodine and its possible association with hyperthyroidism in some districts of Uganda needs urgent investigation.
It is probably appropriate to end this review with two papers: one on eye disorders amongst school children and the other on the role of community health workers in DOTs in South Africa. Drs. Kawuma and Mayeku5 have found a high prevalence of astigmatism and, surprisingly, not short sight! The implications of these refractive disorders are discussed. Kironde and Bajunirwe6 leave us with an interesting debate of a re-emerging health problem with an old solution: using community health workers in DOTs. When you follow the history of primary health care and Alma Ata, you cannot but help beat off the sense of dejavu. Nobody will blame you!
